BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32047722)

  • 1. Fingolimod Augments Monomethylfumarate Killing of GBM Cells.
    Dent P; Booth L; Roberts JL; Poklepovic A; Hancock JF
    Front Oncol; 2020; 10():22. PubMed ID: 32047722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.
    Booth L; Cruickshanks N; Tavallai S; Roberts JL; Peery M; Poklepovic A; Dent P
    Cancer Biol Ther; 2014; 15(12):1646-57. PubMed ID: 25482938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS.
    Tavallai M; Booth L; Roberts JL; McGuire WP; Poklepovic A; Dent P
    Oncotarget; 2016 Apr; 7(14):17290-300. PubMed ID: 26981780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor Signaling.
    Booth L; West C; Hoff DV; Dent P
    Front Oncol; 2020; 10():1331. PubMed ID: 32983965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: Fingolimod Augments Monomethylfumarate Killing of GBM Cells.
    Dent P; Booth L; Roberts JL; Poklepovic A; Hancock JF
    Front Oncol; 2020; 10():684. PubMed ID: 32426288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of autophagy and cell viability by ceramide species.
    Cruickshanks N; Roberts JL; Bareford MD; Tavallai M; Poklepovic A; Booth L; Spiegel S; Dent P
    Cancer Biol Ther; 2015; 16(5):733-42. PubMed ID: 25803131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The irreversible ERBB1/2/4 inhibitor neratinib interacts with the PARP1 inhibitor niraparib to kill ovarian cancer cells.
    Booth L; Roberts JL; Samuel P; Avogadri-Connors F; Cutler RE; Lalani AS; Poklepovic A; Dent P
    Cancer Biol Ther; 2018 Jun; 19(6):525-533. PubMed ID: 29405820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide.
    Booth L; Roberts JL; Poklepovic A; Gordon S; Dent P
    Oncotarget; 2017 Jan; 8(1):1449-1468. PubMed ID: 27903966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDE5 inhibitors enhance celecoxib killing in multiple tumor types.
    Booth L; Roberts JL; Cruickshanks N; Tavallai S; Webb T; Samuel P; Conley A; Binion B; Young HF; Poklepovic A; Spiegel S; Dent P
    J Cell Physiol; 2015 May; 230(5):1115-27. PubMed ID: 25303541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin interacts with sildenafil to kill GI tumor cells via endoplasmic reticulum stress and reactive oxygen/ nitrogen species.
    Roberts JL; Poklepovic A; Booth L
    Oncotarget; 2017 Nov; 8(59):99451-99469. PubMed ID: 29245915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GZ17-6.02 and axitinib interact to kill renal carcinoma cells.
    Booth L; West C; Moore RP; Hoff DV; Dent P
    Oncotarget; 2022; 13():281-290. PubMed ID: 35136485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo.
    Booth L; Roberts JL; Sander C; Lee J; Kirkwood JM; Poklepovic A; Dent P
    Oncotarget; 2017 Mar; 8(10):16367-16386. PubMed ID: 28146421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimethyl fumarate and monomethyl fumarate attenuate oxidative stress and mitochondrial alterations leading to oxiapoptophagy in 158N murine oligodendrocytes treated with 7β-hydroxycholesterol.
    Sghaier R; Nury T; Leoni V; Caccia C; Pais De Barros JP; Cherif A; Vejux A; Moreau T; Limem K; Samadi M; Mackrill JJ; Masmoudi AS; Lizard G; Zarrouk A
    J Steroid Biochem Mol Biol; 2019 Nov; 194():105432. PubMed ID: 31344443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells.
    Booth MR; Booth L; Roberts JL; West C; Dent P
    Oncotarget; 2024 Feb; 15():124-133. PubMed ID: 38329728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lethality of [Pazopanib + HDAC Inhibitors] Is Enhanced by Neratinib.
    Booth L; Roberts JL; Poklepovic A; Dent P
    Front Oncol; 2019; 9():650. PubMed ID: 31380285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
    Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
    J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis.
    Fox RJ; Chan A; Zhang A; Xiao J; Levison D; Lewin JB; Edwards MR; Marantz JL
    Curr Med Res Opin; 2017 Feb; 33(2):175-183. PubMed ID: 27733070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neratinib augments the lethality of [regorafenib + sildenafil].
    Booth L; Roberts JL; Rais R; Cutler RE; Diala I; Lalani AS; Hancock JF; Poklepovic A; Dent P
    J Cell Physiol; 2019 Apr; 234(4):4874-4887. PubMed ID: 30203445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1q/TNF-related peptide 8 (CTRP8) promotes temozolomide resistance in human glioblastoma.
    Thanasupawat T; Glogowska A; Burg M; Krcek J; Beiko J; Pitz M; Zhang GJ; Hombach-Klonisch S; Klonisch T
    Mol Oncol; 2018 Sep; 12(9):1464-1479. PubMed ID: 29949238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OSU-03012 promotes caspase-independent but PERK-, cathepsin B-, BID-, and AIF-dependent killing of transformed cells.
    Yacoub A; Park MA; Hanna D; Hong Y; Mitchell C; Pandya AP; Harada H; Powis G; Chen CS; Koumenis C; Grant S; Dent P
    Mol Pharmacol; 2006 Aug; 70(2):589-603. PubMed ID: 16622074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.